Like a seedling nurtured to become a sturdy tree, India's Production Linked Incentive (PLI) Scheme aims to transform the healthcare manufacturing landscape. With far-reaching objectives such as cultivating a self-reliant industry, fostering innovation, job creation, and export growth, it would be interesting to see whether the scheme turns out to be a game-changer for India's healthcare sector.
The Production Linked Incentive (PLI) Scheme is a strategic initiative by the Indian government to boost domestic manufacturing, enhance exports, and create employment opportunities.
The scheme is available pharmaceutical and medical for devices manufacturers in India. The domestically manufactured pharma products as well as medical devices should meet the prescribed criteria related to production, innovation, and domestic value addition. The incentives are based on incremental sales over the base year of FY 2019-20.
Inaugurated in 2021, with a financial outlay of ₹15,000 crores over six years, the PLI scheme for pharmaceutical manufacturers covers active pharmaceutical ingredients (APIs), formulations (finished dosage forms, such as tablets, capsules, and injectables), and biopharmaceuticals:
• Category 1: Encompassing biopharmaceuticals, complex generic drugs, patented drugs, cell-based or gene therapy drugs, orphan drugs, special empty capsules, and complex excipients.
• Category 2: Focused on bulk drugs, excluding those notified under the "PLI Scheme for Bulk Drugs.
• Category 3: Encompassing drugs not included in Category 1 and Category 2, such as repurposed drugs, auto-immune drugs, anti-cancer drugs, anti-diabetic drugs, antiinfective drugs, cardiovascular drugs, psychotropic drugs, anti-retroviral drugs, and in vitro diagnostic devices.
Denne historien er fra July 2024-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra July 2024-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trigeminal neuralgia patient gains relief
Thumbnail-sized microvascular decompression gives relief to trigeminal neuralgia patient.
IMA forms national alliance to fight AMR
National Alliance of Medical Professionals on Antimicrobial Resistance formed
Abbott launches vertigo awareness campaign
Abbott’s new vertigo awareness campaign, Chakkar Ko Check Kar, aims to raise awareness about the condition that affects about seven-crore Indians.
HCG Cancer Centre hosts fitness challenge for doctors
HCG Cancer Centre Borivali and HCG ICS Khubchandani Cancer Centre, Colaba offer a fitness challenge for doctors on National Doctors’ Day.
IAP launches pediatric cough management awareness campaign
The Indian Academy of Pediatrics (IAP) kickstarts ‘Tackling Cough With Care’ initiative to spread awareness about pediatric cough management.
MedGenome invests in GenX Diagnostics lab
Expands presence in East India with stake acquisition
REVOLUTIONIZING THORACIC SURGERY WITH VATS
Explore how VATS is transforming thoracic surgery with precision, minimal trauma, and rapid recovery.
INTEGRATING AI INTO HEALTHCARE PRACTICES: A LEGAL PERSPECTIVE
Learn the legal challenges for AI adoption in healthcare: across medical devices, negligence, and data protection.
Godrej Consumer unveils breakthrough mosquito repellent
Indian scientists develop new molecule, Renofluthrin, to combat mosquito-borne diseases.
Narayana Health Insurance offers ₹1 cr coverage for surgeries
Narayana Health Insurance launches ‘ADITI’, a health insurance product offering coverage of up to ₹1 crore for surgeries and ₹5 lakh for medical management at Narayana Health.